This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Brainstorms

Antidepressants: The Blue-Chip Psychotropic for the Modern Treatment of Anxiety Disorders

Stephen M. Stahl

Published: June 30, 1999

Article Abstract

This issue of BRAINSTORMS is a visual lesson amplifying last month’s written feature entitled "Mergers and Acquisitions Among Psychotropics: Antidepressant Takeover of Anxiety May Now Be Complete."


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Psychiatry

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...

Read More...